Articles by Daniel Marsh
Keel Infrastructure Shares Tumble After $400M Convertible Note Upsize
Keel Infrastructure shares dropped 12% after pricing a $400M convertible note sale to fund its AI data-center pivot, raising dilution concerns.
Curaleaf Reverse Stock Split Takes Effect, Uplisting Hurdle Remains
Curaleaf executed a 1-for-3 reverse stock split on Friday, boosting its TSX share price to C$15.88, in a bid to meet U.S. listing requirements, as competitor Trulieve gained NYSE approval.
Adyen Stock Plunges 7% on Downgrade, Erasing Recovery
Adyen shares tumbled 7.13% to €833.00 following a negative report from Cleveland Research, erasing Thursday's rebound and extending the year-to-date decline to 39%. Jefferies maintains a Buy rating.
Archer Aviation Shares Dip as Cash Burn Concerns Resurface
Archer Aviation shares fell 2.4% premarket to $6.38 as investors balanced FAA certification progress for the Midnight eVTOL against another quarter of steep spending.
Real Messenger Shares Skyrocket 172% in Pre-Market After Nasdaq Compliance Win
Real Messenger Corp shares surged 172% in pre-market trading after securing Nasdaq compliance and filing for a $9.1M best-efforts offering, though dilution and listing risks remain.
Snap Stock Wavers After Rebound; India Ad Growth Key
Snap shares slipped 0.49% premarket after a 5.9% rebound, as investors weigh surging India ad demand against slowing North American revenue and broader tech declines.
Bio Green Med Stock Surges 170% Pre-Market on All-Stock Future NRG Deal, Massive Dilution Ahead
Bio Green Med shares soared nearly 170% pre-market on an all-stock deal to buy Future NRG, but existing holders will own under 1% of the combined firm, raising dilution concerns.
Celsius Shares Recover as Texas Probe of Alani Nu Sparks Investor Caution
Celsius shares recover 2% in premarket after plunging on news of a Texas probe into Alani Nu's marketing. Analysts at BofA and Morgan Stanley maintain positive ratings.
Reddit Stock Gains on Bullish Analyst Call, Revenue Surge
Reddit shares rose in premarket trading Friday after Loop Capital reaffirmed a Buy rating and $260 price target, implying over 50% upside from recent levels.
Ondas Stock Dips as Share Resale Concerns Offset Defense Contract Gains
Ondas shares slipped 0.9% to $11.86 in premarket trading after a filing registered 2.1M shares for resale, creating an overhang despite $110M in defense orders.
Nu Holdings Launches $1B Buyback Amid Leadership Turmoil
Nu Holdings shares gain 4.1% on a $1B buyback announcement, but a CFO switch and analyst downgrades keep investors wary. BofA slashes price target to $10.
Veru Stock Soars on Novo Nordisk Supply Deal for Obesity Trial
Veru shares jumped 88% to $4.23 after Novo Nordisk agreed to supply Wegovy for Veru's Phase 2b obesity trial. Analysts see it as a validation, but risks remain with trial endpoints and a 60-day exit clause.